Tumor necrosis factor alpha (TNF-α) inhibitors (TNFi) are an important agent for a number of inflammatory conditions, including rheumatoid arthritis (RA), [4] ankylosing spondylitis, [5] and inflammatory bowel disease [6]. The gene discussed is TNF; the disease is inflammatory bowel disease.